Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ivan Valiev

2PUBLICATIONS

50CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|May 06, 2026

Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer.

|Jan 27, 2026

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

Pageof 1

Frequent Collaborators

1 joint publications

Susanne A Gatz

1 joint publications

Pablo Berlanga

1 joint publications

Gwénaël Le Teuff

1 joint publications

Amaury Leruste

1 joint publications

Nicolas André

1 joint publications

Dominique Bluteau

1 joint publications

Nadege Corradini

1 joint publications

Jonathan Rubino

1 joint publications

Fabienne Thomas

1 joint publications

Souad Nebchi

Frequent Collaborators

1 joint publications

Susanne A Gatz

1 joint publications

Pablo Berlanga

1 joint publications

Gwénaël Le Teuff

1 joint publications

Amaury Leruste